Protocol to generate cardiac pericytes from human induced pluripotent stem cells

Mengcheng Shen1, Shane Rui Zhao1, Yaser Khokhar1

  • 1Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

STAR Protocols
|April 29, 2023
PubMed

Insights

Researchers developed a protocol to generate cardiac pericytes from human induced pluripotent stem cells (hiPSCs). This method provides a new way to study coronary microvascular dysfunction.

Area of Science:

  • Cardiovascular Biology
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Cardiac pericytes are crucial for coronary microvasculature function but are difficult to obtain.
  • Understanding cardiac pericyte biology is essential for addressing microvascular dysfunction.

Purpose of the Study:

  • To establish a reliable protocol for generating cardiac pericytes from human induced pluripotent stem cells (hiPSCs).
  • To provide a renewable cell source for studying cardiac pericyte function and dysfunction.

Main Methods:

  • Generation of hiPSC-derived cardiac pericytes through a multi-step differentiation process.
  • Inclusion of intermediate cell types: mid-primitive streak, lateral plate mesoderm, splanchnic mesoderm, septum transversum, and epicardium.

Main Results:

  • Successful derivation of cardiac pericytes from hiPSCs.
  • The protocol provides a scalable method for obtaining these cells.

Conclusions:

  • The developed hiPSC-based protocol offers a valuable tool for cardiac research.
  • This method facilitates the investigation of mechanisms underlying coronary microvascular dysfunction.

Related Concept Videos